{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:39:45Z","timestamp":1787009985815,"version":"build-2736575974"},"reference-count":80,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:p>Placenta accreta spectrum (PAS) disorders have traditionally been characterized based on histopathologic grading, emphasizing the invasion of trophoblasts into the myometrium, and uterine serosa. Recent research has shifted the etiological understanding of PAS, moving away from the concept of aggressive trophoblast invasion to focusing on the critical role of scarred decidual-myometrial interface. This shift highlights the importance of defective scar tissue as a primary factor, reshaping prevention strategies, diagnostic accuracy, and treatment approaches for this increasingly prevalent iatrogenic and morbid pregnancy complication.<\/jats:p>","DOI":"10.1097\/grf.0000000000000929","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T04:00:33Z","timestamp":1745208033000},"page":"310-316","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Updates and Knowledge Gaps in Placenta Accreta Spectrum Biology"],"prefix":"10.1097","volume":"68","author":[{"given":"Lior","family":"Kashani-Ligumsky","sequence":"first","affiliation":[{"name":"Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Scott","sequence":"additional","affiliation":[{"name":"Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Martinez","sequence":"additional","affiliation":[{"name":"Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anhyo","family":"Jeong","sequence":"additional","affiliation":[{"name":"Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ophelia","family":"Yin","sequence":"additional","affiliation":[{"name":"Division of Maternal Fetal Medicine and Reproductive Genetics, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohum","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhen","family":"Zhu","sequence":"additional","affiliation":[{"name":"California NanoSystems Institute, Crump Institute for Molecular Imaging"},{"name":"Department of Molecular and Medical Pharmacology, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3807-7022","authenticated-orcid":false,"given":"Yalda","family":"Afshar","sequence":"additional","affiliation":[{"name":"Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology"},{"name":"Department of Pathology, David Geffen School of Medicine"},{"name":"Molecular Biology Institute, University of California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"R1-20250516","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/AOG.0000000000003793","article-title":"Placenta accreta spectrum disorder: uterine dehiscence, not placental invasion","volume":"135","author":"Einerson","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R2-20250516","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ijgo.15826","article-title":"Looking back to look forward: has the time arrived for active management of obstetricians in placenta accreta spectrum?","volume":"168","author":"Bartels","year":"2025","journal-title":"Int J Gynaecol Obstet"},{"key":"R3-20250516","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1097\/AOG.0000000000002983","article-title":"Obstetric care consensus no. 7: placenta accreta spectrum","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R4-20250516","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/AOG.0000000000000680","article-title":"Morbidly adherent placenta treatments and outcomes","volume":"125","author":"Bailit","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R5-20250516","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0002-9378(97)70463-0","article-title":"Clinical risk factors for placenta previa-placenta accreta","volume":"177","author":"Miller","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"R6-20250516","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.ajog.2004.12.074","article-title":"Abnormal placentation: twenty-year analysis","volume":"192","author":"Wu","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20250516","first-page":"31","article-title":"Placenta accreta: changing clinical aspects and outcome","volume":"56","author":"Read","year":"1980","journal-title":"Obstet Gynecol"},{"key":"R8-20250516","doi-asserted-by":"crossref","first-page":"219.e1","DOI":"10.1016\/j.ajog.2012.12.037","article-title":"Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births","volume":"208","author":"Eshkoli","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20250516","doi-asserted-by":"crossref","first-page":"443.e1","DOI":"10.1016\/j.ajog.2023.10.001","article-title":"Placenta accreta spectrum disorder at single-cell resolution: a loss of boundary limits in the decidua and endothelium","volume":"230","author":"Afshar","year":"2024","journal-title":"Am J Obstetr Gynecol"},{"key":"R10-20250516","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/01.AOG.0000219750.79480.84","article-title":"Maternal morbidity associated with multiple repeat cesarean deliveries","volume":"107","author":"Silver","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R11-20250516","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1471-0528.2008.02037.x","article-title":"Optimal management strategies for placenta accreta","volume":"116","author":"Eller","year":"2009","journal-title":"BJOG"},{"key":"R12-20250516","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMcp1709324","article-title":"Placenta accreta spectrum","volume":"378","author":"Silver","year":"2018","journal-title":"N Engl J Med"},{"key":"R13-20250516","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/AOG.0b013e3181d066d4","article-title":"Maternal outcome after conservative treatment of placenta accreta","volume":"115","author":"Sentilhes","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R14-20250516","doi-asserted-by":"crossref","first-page":"e0201266","DOI":"10.1371\/journal.pone.0201266","article-title":"Increased incidence of respiratory distress syndrome in neonates of mothers with abnormally invasive placentation","volume":"13","author":"Spillane","year":"2018","journal-title":"PLoS ONE"},{"key":"R15-20250516","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1515\/jpm-2013-0199","article-title":"Cesarean section and placental disorders in subsequent pregnancies\u2013a meta-analysis","volume":"42","author":"Klar","year":"2014","journal-title":"J Perinat Med"},{"key":"R16-20250516","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00404-018-4698-4","article-title":"The risk of placenta accreta following primary cesarean delivery","volume":"297","author":"Zeevi","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"R17-20250516","first-page":"799","article-title":"Risk factors for placenta accreta: a large prospective cohort","volume":"31","author":"Bowman","year":"2014","journal-title":"Am J Perinatol"},{"key":"R18-20250516","doi-asserted-by":"crossref","first-page":"568.e1","DOI":"10.1016\/j.ajog.2020.04.026","article-title":"In vitro fertilization as an independent risk factor for placenta accreta spectrum","volume":"223","author":"Salmanian","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R19-20250516","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.fertnstert.2015.01.021","article-title":"Cryopreserved embryo transfer is an independent risk factor for placenta accreta","volume":"103","author":"Kaser","year":"2015","journal-title":"Fertil Steril"},{"key":"R20-20250516","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ajog.2017.05.067","article-title":"Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging","volume":"218","author":"Jauniaux","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R21-20250516","doi-asserted-by":"crossref","first-page":"293","DOI":"10.47162\/RJME.63.2.02","article-title":"Update on placenta accreta spectrum disorders by considering epidemiological factors, ultrasound diagnosis and pathological exam - literature review and authors\u2019 experience","volume":"63","author":"St\u0103nculescu","year":"2022","journal-title":"Rom J Morphol Embryol"},{"key":"R22-20250516","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.3390\/ijms25105102","article-title":"Customizing EV-CATCHER to purify placental extracellular vesicles from maternal plasma to detect placental pathologies","volume":"25","author":"Mitchell","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R23-20250516","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s43032-024-01491-1","article-title":"Shedding of syncytiotrophoblast-derived extracellular vesicles is increased in placenta previa and accreta spectrum","volume":"31","author":"Tersigni","year":"2024","journal-title":"Reprod Sci"},{"key":"R24-20250516","doi-asserted-by":"crossref","first-page":"21922","DOI":"10.1038\/s41598-022-24869-0","article-title":"Circulating microparticle proteins predict pregnancies complicated by placenta accreta spectrum","volume":"12","author":"Yu","year":"2023","journal-title":"Sci Rep"},{"key":"R25-20250516","first-page":"1","article-title":"Pathology of the placenta","volume":"7","author":"Fox","year":"1978","journal-title":"Major Probl Pathol"},{"key":"R26-20250516","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.placenta.2008.04.008","article-title":"Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast","volume":"29","author":"Tantbirojn","year":"2008","journal-title":"Placenta"},{"key":"R27-20250516","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1055\/s-0043-1761635","article-title":"Knowledge gaps in placenta accreta spectrum","volume":"40","author":"Carusi","year":"2023","journal-title":"Am J Perinatol"},{"key":"R28-20250516","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/GRF.0000000000000392","article-title":"Pathophysiology of placenta accreta spectrum disorders: a review of current findings","volume":"61","author":"Jauniaux","year":"2018","journal-title":"Clin Obstetr Gynecol"},{"key":"R29-20250516","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/1933719111426603","article-title":"A look at uterine wound healing through a histopathological study of uterine scars","volume":"19","author":"Roeder","year":"2012","journal-title":"Reprod Sci"},{"key":"R30-20250516","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.placenta.2018.03.003","article-title":"Oxidative stress in placental pathology","volume":"69","author":"Schoots","year":"2018","journal-title":"Placenta"},{"key":"R31-20250516","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00404-017-4432-7","article-title":"Down-regulation of soluble fms-like tyrosine kinase 1 expression in invasive placentation","volume":"296","author":"Shainker","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"R32-20250516","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.ajog.2012.10.270","article-title":"105: Decreased expression of endostatin (ES) and hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) is associated with excessive trophoblast invasion and aberrant angiogenesis in placenta accreta","volume":"208","author":"Duzyj","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"R33-20250516","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/1471-0528.15176","article-title":"Extravillous trophoblast invasion in placenta accreta is associated with differential local expression of angiogenic and growth factors: a cross-sectional study","volume":"125","author":"Duzyj","year":"2018","journal-title":"BJOG"},{"key":"R34-20250516","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/humrep\/14.3.800","article-title":"Relaxin stimulates expression of vascular endothelial growth factor in normal human endometrial cells in vitro and is associated with menometrorrhagia in women","volume":"14","author":"Unemori","year":"1999","journal-title":"Hum Reprod"},{"key":"R35-20250516","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1177\/1933719112472735","article-title":"Relaxin, its receptor (RXFP1), and insulin-like peptide 4 expression through gestation and in placenta accreta","volume":"20","author":"Goh","year":"2013","journal-title":"Reprod Sci"},{"key":"R36-20250516","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s43032-021-00763-4","article-title":"Placenta percreta presents with neoangiogenesis of arteries with Von Willebrand factor-negative endothelium","volume":"29","author":"Schwickert","year":"2022","journal-title":"Reprod Sci"},{"issue":"suppl 2","key":"R37-20250516","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S0049-3848(16)30366-8","article-title":"Endothelial dysfunction in von Willebrand disease: angiogenesis and angiodysplasia","volume":"141","author":"Randi","year":"2016","journal-title":"Thromb Res"},{"key":"R38-20250516","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/373702a0","article-title":"Placental defect and embryonic lethality in mice lacking hepatocyte growth factor\/scatter factor","volume":"373","author":"Uehara","year":"1995","journal-title":"Nature"},{"key":"R39-20250516","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/s13287-021-02487-3","article-title":"EGFL6 regulates angiogenesis and osteogenesis in distraction osteogenesis via Wnt\/\u03b2-catenin signaling","volume":"12","author":"Shen","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"R40-20250516","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.gendis.2020.05.007","article-title":"THBS1 regulates trophoblast fusion through a CD36-dependent inhibition of cAMP, and its upregulation participates in preeclampsia","volume":"8","author":"Duan","year":"2021","journal-title":"Genes Dis"},{"key":"R41-20250516","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/molehr\/gar067","article-title":"Gene expression profiling of placentae from women with early- and late-onset pre-eclampsia: down-regulation of the angiogenesis-related genes ACVRL1 and EGFL7 in early-onset disease","volume":"18","author":"Junus","year":"2012","journal-title":"Mol Hum Reprod"},{"key":"R42-20250516","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1080\/15384101.2019.1689481","article-title":"HIF-1\u03b1 regulates angiogenesis via Notch1\/STAT3\/ETBR pathway in trophoblastic cells","volume":"18","author":"Yu","year":"2019","journal-title":"Cell Cycle"},{"key":"R43-20250516","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000147847","article-title":"Epithelial-mesenchymal transition during trophoblast differentiation","volume":"156","author":"Vi\u0107ovac","year":"1996","journal-title":"Acta Anat (Basel)"},{"key":"R44-20250516","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/annonc\/mdh387","article-title":"Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas","volume":"15","author":"Faleiro-Rodrigues","year":"2004","journal-title":"Ann Oncol"},{"key":"R45-20250516","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1158\/0008-5472.CAN-07-0929","article-title":"Fascin, a novel target of \u03b2-catenin-TCF signaling, is expressed at the invasive front of human colon cancer","volume":"67","author":"Vignjevic","year":"2007","journal-title":"Cancer Res"},{"key":"R46-20250516","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10555-008-9179-y","article-title":"E-cadherin, \u03b2-catenin, and ZEB1 in malignant progression of cancer","volume":"28","author":"Schmalhofer","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"R47-20250516","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.placenta.2015.04.001","article-title":"The invasive phenotype of placenta accreta extravillous trophoblasts associates with loss of E-cadherin","volume":"36","author":"Duzyj","year":"2015","journal-title":"Placenta"},{"key":"R48-20250516","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1177\/1933719118792095","article-title":"Changes in vasodilator-stimulated phosphoprotein phosphorylation, profilin-1, and cofilin-1 in accreta and protection by DHA","volume":"26","author":"Ali","year":"2019","journal-title":"Reprod Sci"},{"key":"R49-20250516","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/jcp.26098","article-title":"The depletion of MARVELD1 leads to murine placenta accreta via integrin \u03b24-dependent trophoblast cell invasion","volume":"233","author":"Chen","year":"2018","journal-title":"J Cell Physiol"},{"key":"R50-20250516","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1007\/s00018-014-1691-3","article-title":"Physiological and pathological consequences of cellular senescence","volume":"71","author":"Burton","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"R51-20250516","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejogrb.2024.02.045","article-title":"Uterine wound healing after caesarean section: a systematic review","volume":"296","author":"Debras","year":"2024","journal-title":"Eur J Obstetr Gynecol Reproduct Biol"},{"key":"R52-20250516","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/aji.12466","article-title":"Decidual control of trophoblast invasion","volume":"75","author":"Sharma","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"R53-20250516","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"R54-20250516","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexcr.2017.02.041","article-title":"Epithelial-mesenchymal transition in morphogenesis, cancer progression and angiogenesis","volume":"353","author":"Ribatti","year":"2017","journal-title":"Exp Cell Res"},{"key":"R55-20250516","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1177\/1933719117749753","article-title":"The role and molecular mechanism of long nocoding RNA-MEG3 in the pathogenesis of preeclampsia","volume":"25","author":"Yu","year":"2018","journal-title":"Reprod Sci"},{"key":"R56-20250516","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/15513815.2020.1843574","article-title":"Possible role of TGF-\u03b21, MMP-2, E-CAD, \u03b2-catenin and antioxidants in pathogenesis of placenta accreta","volume":"40","author":"El-Hussieny","year":"2021","journal-title":"Fetal Pediatr Pathol"},{"key":"R57-20250516","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1067\/S0002-9378(03)00468-X","article-title":"Collagen content and growth factor immunoexpression in uterine lower segment of type IA osteogenesis imperfecta: Relationship with recurrent uterine rupture in pregnancy","volume":"189","author":"Di Lieto","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R58-20250516","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ni.3131","article-title":"Immune mechanisms at the maternal-fetal interface: perspectives and challenges","volume":"16","author":"PrabhuDas","year":"2015","journal-title":"Nat Immunol"},{"key":"R59-20250516","doi-asserted-by":"crossref","first-page":"e13611","DOI":"10.1111\/aji.13611","article-title":"Macrophage polarization in placenta accreta and macrophage-trophoblast interactions","volume":"88","author":"Che","year":"2022","journal-title":"Am J Rep Immunol"},{"key":"R60-20250516","doi-asserted-by":"crossref","first-page":"816","DOI":"10.5603\/gpl.95458","article-title":"FOXP3-positive cell infiltration in the chorionic villi is increased in the placenta accreta and decreased in the placental abruption","volume":"94","author":"Dutsch-Wicherek","year":"2023","journal-title":"Ginekol Pol"},{"key":"R61-20250516","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.placenta.2014.03.004","article-title":"Differences in regulatory T-cell and dendritic cell pattern in decidual tissue of placenta accreta\/increta cases","volume":"35","author":"Schwede","year":"2014","journal-title":"Placenta"},{"key":"R62-20250516","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/imm.12218","article-title":"The up side of decidual natural killer cells: new developments in immunology of pregnancy","volume":"141","author":"Jabrane-Ferrat","year":"2014","journal-title":"Immunology"},{"key":"R63-20250516","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.placenta.2022.01.002","article-title":"Uterine damage induces placenta accreta and immune imbalance at the maternal-fetal interface in the mouse","volume":"119","author":"Zhou","year":"2022","journal-title":"Placenta"},{"key":"R64-20250516","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/uog.24861","article-title":"Diagnosis of placenta accreta spectrum in high-risk women using ultrasonography or magnetic resonance imaging: systematic review and meta-analysis","volume":"59","author":"De Oliveira Carniello","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R65-20250516","doi-asserted-by":"crossref","first-page":"860186","DOI":"10.3389\/fmed.2022.860186","article-title":"Potential serum biomarkers in prenatal diagnosis of placenta accreta spectrum","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Med"},{"key":"R66-20250516","doi-asserted-by":"crossref","first-page":"156513","DOI":"10.1016\/j.cyto.2024.156513","article-title":"Evaluation of maternal serum VEGF, TNF-alpha, IL-4, and IL-10 levels in differentiating placenta accreta spectrum from isolated placenta previa","volume":"176","author":"Fariso\u011fullari","year":"2024","journal-title":"Cytokine"},{"key":"R67-20250516","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/AOG.0000000000004107","article-title":"Screening for fetal chromosomal abnormalities: ACOG practice bulletin summary, number 226","volume":"136","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R68-20250516","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/AOG.0b013e31824fb482","article-title":"Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing","volume":"119","author":"Bianchi","year":"2012","journal-title":"Obstetr Gynecol"},{"key":"R69-20250516","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet"},{"key":"R70-20250516","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/pd.4103","article-title":"Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y: validation study of cfDNA testing using SNPs","volume":"33","author":"Nicolaides","year":"2013","journal-title":"Prenat Diagn"},{"key":"R71-20250516","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","article-title":"Cell-free DNA analysis for noninvasive examination of trisomy","volume":"372","author":"Norton","year":"2015","journal-title":"N Engl J Med"},{"key":"R72-20250516","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/clinchem\/48.2.353","article-title":"Increased cell-free fetal DNA in plasma of two women with invasive placenta","volume":"48","author":"Sekizawa","year":"2002","journal-title":"Clin Chem"},{"key":"R73-20250516","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/pd.4195","article-title":"Fraction of cell-free fetal DNA in the maternal serum as a predictor of abnormal placental invasion-a pilot study","volume":"33","author":"Samuel","year":"2013","journal-title":"Prenat Diagn"},{"key":"R74-20250516","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1073\/pnas.0637450100","article-title":"mRNA of placental origin is readily detectable in maternal plasma","volume":"100","author":"Ng","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R75-20250516","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrg1982","article-title":"Prenatal diagnosis: progress through plasma nucleic acids","volume":"8","author":"Lo","year":"2007","journal-title":"Nat Rev Genet"},{"key":"R76-20250516","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.placenta.2014.07.007","article-title":"Maternal plasma levels of cell-free \u03b2-HCG mRNA as a prenatal diagnostic indicator of placenta accrete","volume":"35","author":"Zhou","year":"2014","journal-title":"Placenta"},{"key":"R77-20250516","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijgo.2009.11.013","article-title":"Cell-free placental mRNA in maternal plasma to predict placental invasion in patients with placenta accreta","volume":"109","author":"El Behery","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"R78-20250516","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1038\/s41467-021-24627-2","article-title":"Circulating trophoblast cell clusters for early detection of placenta accreta spectrum disorders","volume":"12","author":"Afshar","year":"2021","journal-title":"Nat Commun"},{"key":"R79-20250516","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3109\/01443615.2013.823388","article-title":"Increased incidence of placenta praevia and accreta with previous caesareans\u2013a hypothesis for causation","volume":"33","author":"Sholapurkar","year":"2013","journal-title":"J Obstet Gynaecol"},{"key":"R80-20250516","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0140-6736(16)00204-X","article-title":"Caesarean section surgical techniques: 3 year follow-up of the CORONIS fractional, factorial, unmasked, randomised controlled trial","volume":"388","author":"Abalos","year":"2016","journal-title":"Lancet"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000929","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T09:02:16Z","timestamp":1747386136000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000929","relation":{},"ISSN":["0009-9201","1532-5520"],"issn-type":[{"value":"0009-9201","type":"print"},{"value":"1532-5520","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]}}}